pVasc Brochure
Product brochure to be used as leave behind piece as needed.
pVasc Procedure Guide
Pocket guide to be shared with newly initiated sites and/or existing customers as a leave behind piece. Contact Market Development for help in organizing a pVasc Induction Webinar with your customer if needed.
pVasc Roll Up Banners
PDFs to download and print as roll-up banners to use at local meetings and events.
pVasc Print Ad
PDF to download and share with print media. No changes are allowed.
Vesalio Announces Launch of pVasc Study in the U.S. While Featuring the pVasc Thrombectomy System at VIVA, VEITH, and TCT
Vesalio Introduces pVasc™ U.S. Clinical Study to capture real-world data and optimize results for patients suffering from peripheral vascular disease.
NeVa CLEAR Study results presented at ESMINT: innovative thrombectomy device achieves notable first-pass success and patient outcomes
Primary results from the CLEAR Study were presented at the ESMINT annual meeting in Marseille, France (4-6 September 2023), where Vesalio also announced the fifth anniversary of the international commercialization of the NeVa™ device.
Vesalio appoints VP of U.S. Sales and announces recent publication on NeVa showing impressive first pass rates
Vesalio hires Bob Bushok as VP of U.S. Sales and announces high first-pass rates and favorable safety profile in a 145-stroke patient data set for the NeVa™ thrombectomy device with findings published in the journal Interventional Neuroradiology.
Vesalio announces EU MDR Certification
MDR certification confirms the company’s commitment of ensuring that their innovative new products meet or exceed these rigorous new standards.
Vesalio announces FDA Approval of the NeVa VS™
NeVa VS is a patented retrievable nitinol stent specifically designed to treat cerebral vasospasm after aneurysmal rupture.
Vesalio announces CE Approval for new NeVa NET™
The first integrated clot micro-filtration technology for stroke thrombectomy patients.
